Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,734,000 | 2,022,000 | 1,724,000 | 370,000 | 217,000 |
| Receivables | 1,531,000 | 1,598,000 | 1,457,000 | 1,577,000 | 1,828,000 |
| Inventories | 1,351,000 | 1,472,000 | 1,516,000 | 1,628,000 | 1,579,000 |
| Other current assets | 1,884,000 | 894,000 | 925,000 | 1,043,000 | 880,000 |
| TOTAL | $6,694,000 | $6,160,000 | $5,803,000 | $4,823,000 | $4,699,000 |
| Non-Current Assets | |||||
| PPE Net | 2,084,000 | 2,064,000 | 2,079,000 | 2,098,000 | 2,079,000 |
| Intangibles | 15,868,000 | 16,934,000 | 17,261,000 | 17,491,000 | 18,062,000 |
| Other Non-Current Assets | 6,131,000 | 5,688,000 | 5,682,000 | 5,700,000 | 5,725,000 |
| TOTAL | $24,083,000 | $24,686,000 | $25,022,000 | $25,289,000 | $25,866,000 |
| Total Assets | $30,777,000 | $30,845,000 | $30,823,000 | $30,113,000 | $30,565,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,000 | 11,000 | 254,000 | 1,004,000 | 1,416,000 |
| Accounts payable and accrued liabilities | 513,000 | 452,000 | 408,000 | 605,000 | 542,000 |
| Accrued Expenses | 2,197,000 | 2,195,000 | 1,718,000 | 1,562,000 | 2,109,000 |
| Other current liabilities | 958,000 | 644,000 | 729,000 | 804,000 | 800,000 |
| TOTAL | $3,681,000 | $3,302,000 | $3,108,000 | $3,976,000 | $4,866,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,130,000 | 9,325,000 | 9,278,000 | 9,331,000 | 8,592,000 |
| Other Non-Current Liabilities | 2,309,000 | 2,132,000 | 2,236,000 | 2,412,000 | 2,635,000 |
| TOTAL | $11,769,000 | $11,979,000 | $12,099,000 | $12,332,000 | $11,822,000 |
| Total Liabilities | $15,451,000 | $15,281,000 | $15,207,000 | $16,309,000 | $16,688,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,417,166 | 1,431,921 | 1,430,675 | 1,399,350 | 1,396,195 |
| Common Shares | 17,000 | 17,000 | 17,000 | 16,000 | 16,000 |
| Retained earnings | -2,378,000 | -2,574,000 | -2,405,000 | -2,252,000 | -2,253,000 |
| Other shareholders' equity | 206,000 | 151,000 | 131,000 | 168,000 | 270,000 |
| TOTAL | $15,326,000 | $15,564,000 | $15,616,000 | $13,804,000 | $13,877,000 |
| Total Liabilities And Equity | $30,777,000 | $30,845,000 | $30,823,000 | $30,113,000 | $30,565,000 |